Biopharmaceutical Research on the Choice of a Non-Steroidal Anti-Inflammatory Agent in the Development of Combination Gel for Mastopathy Therapy

    September 2020 in “ Zenodo (CERN European Organization for Nuclear Research) ”
    S. S. Zuіkina, L. І. Vyshnevska

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary In this study, researchers identified indometacin as a suitable active ingredient for a combination gel aimed at treating mastopathy and preventing breast cancer, establishing its concentration using literary analysis, marketing research, and in vitro biopharmaceutical methods.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on zenodo.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Development of Mask-Cream Technology with Herbal Substances for the Androgenic Alopecia Treatment ScienceRise · 2017